When malaria strikes, the choice of drug can mean the difference between a quick recovery and a painful relapse. Primaquine has been the go‑to medicine for preventing relapse of Plasmodium vivax infections, but newer options like tafenoquine and classic agents such as chloroquine or mefloquine also show up in treatment plans. This guide walks you through the key factors that matter - efficacy, safety, dosing convenience, and who should avoid each drug - so you can decide which option fits your situation.
Quick Takeaways
- Primaquine is highly effective for preventing vivax and ovale relapses but requires a 14‑day course.
- Tafenoquine offers a single‑dose radical cure, but it’s only approved for G6PD‑normal patients.
- Chloroquine works well for chloroquine‑sensitive strains but is losing ground where resistance is common.
- Mefloquine provides weekly prophylaxis but carries a higher risk of neuropsychiatric side effects.
- Doxycycline is a solid alternative for travelers, especially when resistance limits other options.
Why the Choice Matters
Malaria isn’t a one‑size‑fits‑all disease. Plasmodium vivax forms dormant liver stages called hypnozoites that can reactivate weeks or months after the initial infection. The only drugs that clear these hypnozoites are known as radical cure agents - primaquine and tafenoquine. If you miss the radical cure, the parasite can bounce back, leading to repeated fevers, chills, and missed work or school.
Key Comparison Table
Drug | Mechanism | Standard Adult Dose | Half‑Life | FDA Status (US) | Key Safety Concern |
---|---|---|---|---|---|
Primaquine | Oxidative stress on parasite mitochondria | 0.5mg/kg daily for 14days (radical cure) | ≈6hours | Approved | Hemolysis in G6PD‑deficiency |
Tafenoquine | Similar oxidative pathway, longer‑acting | 300mg single dose (plus 3‑day loading) | ≈14days | Approved (2021) for radical cure | G6PD‑deficiency, eye toxicity (rare) |
Chloroquine | Inhibits heme polymerization | 600mg base then 300mg weekly (treatment) | ≈1-2weeks | Approved | Resistance in many endemic regions |
Mefloquine | Disrupts parasite membrane function | 250mg weekly (preventive) or 1250mg single dose (treatment) | ≈20days | Approved | Neuro‑psychiatric effects |
Doxycycline | Inhibits protein synthesis | 100mg daily (starting 1day before exposure, continue 4weeks after) | ≈18hours | Approved | Photosensitivity, GI upset |

How to Pick the Right Drug
Think of drug selection as a decision tree. First, ask yourself: Do I need a radical cure? If you’re dealing with Plasmodium vivax or Plasmodium ovale, the answer is yes. Next, check your G6PD status - a simple blood test can tell you if you’re deficient. If you’re G6PD‑normal, tafenoquine’s single dose is a huge convenience. If you’re deficient or can’t get testing, stick with primaquine and follow the 14‑day regimen carefully. If you’re traveling to an area where chloroquine resistance is high (Southeast Asia, parts of Africa), move to alternatives like doxycycline or mefloquine for prophylaxis. Doxycycline works well in most regions but requires daily dosing and can cause sunburn - not ideal for beach vacations. Mefloquine offers weekly dosing, but the neuro‑psychiatric risk is a deal‑breaker for anyone with a history of anxiety or depression.
Safety First: G6PD Deficiency and Other Risks
Both primaquine and tafenoquine cause oxidative damage to red blood cells. In people with G6PD deficiency, this can trigger severe hemolysis, leading to dark urine, jaundice, and possibly kidney failure. The safest route is a screening test before starting either drug. If deficiency is confirmed, the only reliable option is to use a non‑oxidative regimen - typically chloroquine (if sensitive) followed by a 4‑week course of doxycycline for blood‑stage clearance.
Other side‑effects to watch:
- Primaquine: Nausea, abdominal cramps, methemoglobinemia (rare).
- Tafenoquine: Visual disturbances - patients should report any changes in vision immediately.
- Mefloquine: Dizziness, vivid dreams, anxiety; stop immediately if severe.
- Doxycycline: Esophageal irritation - take with plenty of water and stay upright.
Cost and Availability in 2025
In the United States, primaquine 15‑mg tablets cost about $30 for a 14‑day pack, while tafenoquine’s single‑dose regimen runs roughly $140 - a big jump, but many insurers cover it when G6PD testing is documented. Chloroquine remains cheap (<$10 for a standard treatment course) but its usefulness is limited by resistance patterns published by the WHO in 2024. Mefloquine and doxycycline sit in the $20‑$50 range, with doxycycline being widely available over the counter in many countries.

Practical Tips for Patients
- Get a G6PD test before starting primaquine or tafenoquine.
- Take primaquine with food to reduce stomach upset.
- If you miss a dose of primaquine, take it as soon as you remember, then continue the schedule - don’t double‑dose.
- For weekly mefloquine, set a reminder on your phone; skipping a dose can lower efficacy.
- When using doxycycline, avoid excessive sun exposure and wear sunscreen.
Frequently Asked Questions
Can I take primaquine and tafenoquine together?
No. Both drugs act on the same oxidative pathway and increase the risk of hemolysis. Choose one based on G6PD status and convenience.
Is primaquine effective against Plasmodium falciparum?
Primaquine has some activity against the gametocyte stage of falciparum, reducing transmission, but it is not a primary treatment for blood‑stage infection. Combine it with a fast‑acting drug like artemisinin.
What should I do if I develop dark urine while on primaquine?
Dark urine may signal hemolysis. Stop the drug, hydrate, and seek medical attention immediately. A healthcare provider will check bilirubin and hemoglobin levels.
How long after finishing primaquine can I travel again?
You can travel right after completing the 14‑day course, provided you have no lingering side‑effects and your G6PD status is normal.
Are there pediatric doses for tafenoquine?
Tafenoquine is approved for patients 16years and older. For younger children, primaquine remains the pediatric radical cure option.
Bottom Line
If you need a one‑off cure and you’re G6PD‑normal, tafenoquine’s single dose beats the 14‑day piano‑practice‑like regimen of primaquine. If you can’t rule out G6PD deficiency or you’re looking for a lower‑cost option, stick with primaquine and follow dosing rules closely. For prophylaxis in resistant areas, doxycycline or mefloquine are the practical choices, each with its own trade‑off of daily versus weekly pills and side‑effect profiles. Always pair the drug decision with a brief discussion with your clinician - a short conversation can prevent a costly relapse later.
1 Comments
When considering primaquine, the first step should always be a G6PD screening. Without that safety net, you risk hemolytic anemia, which can be life‑threatening. The test is quick, inexpensive, and widely available in travel clinics. Once you have a clear result, you can confidently follow the 14‑day regimen.